Gatifloxacin recalls
The FDA has published 5 recalls involving Gatifloxacin since 2014. The latest was reported on 12 Jan 2022. Most were for potency & assay. Lupin Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls5since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 12 Jan 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 20%Class III 4 80%
Why gatifloxacin is recalled
Companies
By year
All gatifloxacin recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Gatifloxacin Ophthalmic Solution recalled by Lupin Pharmaceuticals | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Gatifloxacin Ophthalmic Solution recalled by Lupin Pharmaceuticals | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only recalledGatifloxacin | Sandoz | Packaging Defects | Nationwide |
| Drug | CLASS III | Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only recalled | Lupin Pharmaceuticals | Labeling Errors | Nationwide |
| Drug | CLASS II | Gatifloxacin 0.5% (ophthalmic) recalled by Specialty Medicine | Specialty Medicine Compounding Pharmacy | Sterility | MI |
Should you stop taking Gatifloxacin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.